Isomorphic Labs has raised $5 billion in a Series C funding round to accelerate its artificial intelligence-driven drug discovery efforts and advance its internal pipeline toward clinical trials.…
Isomorphic Labs has raised $5 billion in a Series C funding round to accelerate its artificial intelligence-driven drug discovery efforts and advance its internal pipeline toward clinical trials. The round was co-led by venture capital firms Greenoaks and Sequoia Capital, alongside Andreessen Horowitz, with continued backing from parent company Alphabet. Existing investors including Thrive Capital, […] The post Isomorphic Labs raises US$5B in Series C round appeared first on Frontier Enterprise.
This is a source-linked briefing. Read the original report from Frontier Enterprise .